H

HealthCare Global Enterprises Limited

HCGNSE
Market snapshot · 2026-08-11 06:42 UTC

₹718.35

+₹2.70 (+0.38%)

MARKET CAP

₹10.73K Cr

STOCK P/E

756.2x

52W HIGH

₹804.65

52W LOW

₹513.30

BOOK VALUE

₹92.07

EPS

₹0.95

ROE

—

SECTOR

Health Care

DEBT/EQUITY

123.06

VOLUME

1.01L

P/B RATIO

7.80x

PEG RATIO

4.43

Sector

Health Care

Themes

Hospitals & Diagnostic Centres
E
Earnings
₹759.60₹701.63₹643.65₹585.68₹527.70VolumeEEEEAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Trading 42.7% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +1.7). Confidence: 75%.

Live forward EPS implies next-12-month EPS of ₹14.58. Applying the stock's normalized valuation corridor produces a fair range of ₹5,658.21 to ₹9,253.78, with base value near ₹7,727.69 (+975.8% vs current price).

Forward Valuation Outlook

Live forward estimate anchored to the company's historical valuation corridor.

Below normalized range

Forward EPS

₹14.58

Forward P/E

49.3x

Base Fair Value

₹7,727.69

Fair Range

₹5,658.21 - ₹9,253.78

Upside To Base

+975.8%

Estimate Source

Live forward EPS

Growth Estimate

+170.6%

P/E
Strongly Overvalued

5Y Average

329.86

Current

756.16

Overvalued

634.69

Undervalued

388.08

P/S
Strongly Overvalued

5Y Average

2.37

Current

4.07

Overvalued

2.73

Undervalued

2.02

P/B
Strongly Undervalued

5Y Average

9.20

Current

7.80

Overvalued

10.41

Undervalued

8.05

Peers & Comparison

Sector: Health Care · Theme: Hospitals & Diagnostic Centres

Hospitals & Diagnostic Centres Peers8 peers
Avg P/E: 72x
CompanyRev. GrowthMarginP/Evs Avg52W Perf.
RAINBOW CHILDRENS MED LTD
RAINBOWHospitals & Diagnostic Centres
+33.2%15.7%
54.6x
Undervalued
-24% vs avg
+3.5%
PARK MEDI WORLD LIMITED
PARKHOSPSHospitals & Diagnostic Centres
+19.3%16.1%
44.1x
Undervalued
-39% vs avg
+97.5%
METROPOLIS HEALTHCARE LTD
METROPOLISHospitals & Diagnostic Centres
+16.6%11.8%
58.8x
Undervalued
-18% vs avg
+10.2%
JUPITER LIFE LINE HOSP L
JLHLHospitals & Diagnostic Centres
+18.2%12.0%
55.8x
Undervalued
-23% vs avg
+11.3%
NEPHROCARE HEALTH SERV L
NEPHROPLUSHospitals & Diagnostic Centres
+21.2%7.7%
85.9x
Premium
+19% vs avg
+47.3%
NARAYANA HRUDAYALAYA LTD.
NHHospitals & Diagnostic Centres
+80.4%9.0%
45.3x
Undervalued
-37% vs avg
+6.8%
GLOBAL HEALTH LIMITED
MEDANTAHospitals & Diagnostic Centres
+26.5%11.9%
71.4x
Fair
-1% vs avg
+4.9%
KRISHNA INST OF MED SCI L
KIMSHospitals & Diagnostic Centres
+35.3%4.8%
160.4x
Premium
+123% vs avg
+11.6%
WHY THESE PEERS

HEALTHCARE GLOB. ENT. LTD trades at a premium (753.3x vs peer avg 72.0x), implying higher growth or quality expectations from the Hospitals & Diagnostic Centres cohort. Peers include RAINBOW CHILDRENS MED LTD, PARK MEDI WORLD LIMITED, METROPOLIS HEALTHCARE LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹377 CrJun 2026

Latest net profit

₹5.58 CrJun 2026

Latest EPS

₹0.37Jun 2026

Net margin

15.7%Jun 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q1 '26Q2 '26Q3 '26Q4 '26Q1 '270.0%6.0%12.0%18.0%24.0%-130 Cr0.00 Cr130 Cr260 Cr390 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q1 '26Q2 '26Q3 '26Q4 '26Q1 '270.00 Cr95 Cr190 Cr285 Cr380 Cr₹-0₹0₹0₹1₹1
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherNet Profit0.00 Cr95 Cr190 Cr285 Cr380 Cr

Latest reported period: Jun 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2022Mar 2023Mar 2024Mar 2025Mar 20260.00 Cr750 Cr1.50K Cr2.25K Cr3.00K Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales +272.23282.75285.81299.93293.61329.25312.51324.38327.09345.84342.16350.21376.66
Expenses +224.69232.34237.06243.32243.72267.67270.19265.49277.24283.54287.86275.07317.44
Operating Profit47.5450.4148.7556.6149.8961.5842.3258.8949.8562.3054.3075.1459.22
OPM %17.46%17.83%17.06%18.87%16.99%18.70%13.54%18.15%15.24%18.01%15.87%21.46%15.72%
Other Income +1.832.135.04-12.4310.509.79-29.539.467.943.82-4.87-32.609.56
Interest9.6910.9813.7014.6119.3420.5821.2722.5024.3021.3620.6120.1921.73
Depreciation21.6423.2824.8025.9025.8427.8827.9029.0528.2530.1630.0931.3039.57
Profit before tax18.0418.2815.293.6715.2122.91-36.3816.805.2414.60-1.27-8.957.48
Tax %24.11%25.05%43.30%145.78%22.95%21.65%2.61%39.58%34.16%26.16%-7.09%-117.09%25.40%
Net Profit +13.6913.708.67-1.6811.7217.95-37.3310.153.4510.78-1.181.535.58
EPS in Rs0.930.930.59-0.110.791.22-2.530.690.230.72-0.080.100.37
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderMar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters71.22%62.46%63.78%63.77%64.21%
FII2.44%2.16%3.59%3.22%2.76%
DII12.48%13.22%18.36%18.30%18.91%
Public10.43%10.50%10.42%11.20%10.80%
Others3.43%11.66%3.85%3.51%3.32%
Mar 2026
Promoters
FII
DII
Public
Others

Events Timeline

Announcement under Regulation 30 (LODR)-Newspaper Publication

Aug 08, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Aug 07, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Aug 07, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Press Release / Media Release

Aug 06, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Investor Presentation

Aug 06, 2026PDFCompany Reports Open